Targeted optical fluorescence imaging: a meta‑narrative review and future perspectives.
Schouw, H. M., Huisman, L. A., Janssen, Y. F., Slart, R. H. J. A., Borra, R. J. H., Willemsen, A. T. M., Brouwers, A. H., van Dijl, J. M., Dierckx, R. A., van Dam, G. M., Szymanski, W., Boersma, H. H., Kruijff, S. European Journal Of Nuclear Medicine And Molecular Imaging. doi: 10.1007/s00259-021-05504-y
Personalized type 2 diabetes treatment in primary care: insights using real world data
Martina Ambrož - Personalized type 2 diabetes treatment in primary care: insights using real world data.
This thesis examines personalized treatment for individuals with type 2 diabetes (T2D) in primary care. We studied glycated hemoglobin A1c (HbA1c) and systolic blood pressure (SBP) levels at the start of glucose- and blood pressure-lowering medication between 2007 and 2020. Surprisingly, no significant differences were found based on age or frailty, highlighting a lack of personalized treatment. Another study revealed more hypotension-related adverse events in older patients, those with polypharmacy, and lower SBP levels, emphasizing the need for tailored approaches. Sex differences in medication prescribing were identified, with females less likely to receive certain medications. Females with T2D also showed age-specific variations in LDL cholesterol levels, suggesting the need for sex-specific treatment recommendations. Additionally, patients' willingness to engage in different treatments varied, with only half open to all options. These findings underscore the importance of personalized approaches in T2D treatment, requiring attention in clinical practice and future research.
Fluorescence-guided imaging for resection margin evaluation in head and neck cancer patients using cetuximab-800CW: A quantitative dose-escalation study.
Floris Jan Voskuil, Steven Jakob de Jongh, Wouter Tjerk Rudolph Hooghiemstra, Matthijs David Linssen, Pieter Jan Steinkamp, Sebastiaan Antonius Hendrik Johannes de Visscher, Kees-Pieter Schepman, Sjoerd Geert Elias, Gert-Jan Meersma, Pascal Klaas Christiaan Jonker, Jan Johannes Doff, Annelies Jorritsma-Smit, Wouter Bastiaan Nagengast, Bert van der Vegt, Dominic James Robinson, Gooitzen Michell van Dam, Max Johannes Hendrikus Witjes
Theranostics 2020; 10(9): 3994-4005. doi:10.7150/thno.43227
Implementation and benchmarking of a novel analytical framework to clinically evaluate tumor-specific fluorescent tracers.
Koller M, Qiu SQ, Linssen MD, Jansen L, Kelder W, de Vries J, Kruithof I, Zhang GJ, Robinson DJ, Nagengast WB, Jorritsma-Smit A, van der Vegt B, van Dam GM. Nat Commun. 2018 Sep 18;9(1):3739. doi: 10.1038/s41467-018-05727-y. PubMed PMID: 30228269; PubMed Central PMCID: PMC6143516.
Tumor-Specific Uptake of Fluorescent Bevacizumab-IRDye800CW Microdosing in Patients with Primary Breast Cancer: A Phase I Feasibility Study.
Lamberts LE, Koch M, de Jong JS, Adams ALL, Glatz J, Kranendonk MEG, Terwisscha van Scheltinga AGT, Jansen L, de Vries J, Lub-de Hooge MN, Schröder
CP, Jorritsma-Smit A, Linssen MD, de Boer E, van der Vegt B, Nagengast WB, Elias SG, Oliveira S, Witkamp AJ, Mali WPTM, Van der Wall E, van Diest PJ, de Vries
EGE, Ntziachristos V, van Dam GM. Clin Cancer Res. 2017 Jun 1;23(11):2730-2741. doi:10.1158/1078-0432.CCR-16-0437. Epub 2016 Nov 9. PubMed PMID: 28119364.
Treshold Analysis and Biodistribution of Fluorescently Labeled Bevacizumab in Human Breast Cancer.
Koch M, de Jong JS, Glatz J, Symvoulidis P, Lamberts LE, Adams AL, Kranendonk ME, Terwisscha van Scheltinga AG, Aichler M, Jansen L, de Vries J, Lub-de Hooge MN, Schröder CP, Jorritsma-Smit A, Linssen MD, de Boer E, van der Vegt B, Nagengast WB, Elias SG, Oliveira S, Witkamp AJ, Mali WP, Van der Wall E, Garcia-Allende PB, van Diest PJ, de Vries EG, Walch A, van Dam GM, Ntziachristos V. Cancer Res. 2017 Feb 1;77(3):623-631. doi:10.1158/0008-5472.CAN-16-1773. Epub 2016 Nov 22. PubMed PMID: 27879266.
Molecular imaging of infectious and inflammatory diseases: a terra incognita
Glaudemans AW, Slart RH, van Dijl JM, van Oosten M, van Dam GM. J Nucl Med. 2015 May;56(5):659-61. doi: 10.2967/jnumed.115.155119. Epub 2015 Mar 26. PubMed PMID: 25814517.
Mesoscopic and macroscopic optoacoustic imaging of cancer.
Taruttis A, van Dam GM, Ntziachristos V. Cancer Res. 2015 Apr 15;75(8):1548-59. doi: 10.1158/0008-5472.CAN-14-2522. Epub 2015 Apr 2. Review. PubMed PMID: 25836718.
de Boer E, Harlaar NJ, Taruttis A, Nagengast WB, Rosenthal EL, Ntziachristos V, van Dam GM. Br J Surg. 2015 Jan;102(2):e56-72. doi: 10.1002/bjs.9713. Review. PubMed PMID: 25627136.
Warram JM, de Boer E, Sorace AG, Chung TK, Kim H, Pleijhuis RG, van Dam GM, Rosenthal EL. Cancer Metastasis Rev. 2014 Sep;33(2-3):809-22. doi: 10.1007/s10555-014-9505-5. Review. PubMed PMID: 24913898; PubMed Central PMCID: PMC4116453.
We use cookies to optimize your experience and analyze traffic on our website. By clicking 'Accept all,' you consent to the use of all cookies. You can customize your preferences by clicking on 'Settings' or read our privacy policy for more information.
Essential cookies
These cookies make sure the website functions properly. These cookies also provide us to anonymously monitor website statistics. Because these cookies are essential for the website, you can not disable them without compromising the functionality of the website.
Analytical cookies
These cookies collect data that we use to understand how our website is used and perceived. These cookies also help us to optimize the website for the best user experience.
Advertising cookies
These cookies allow ad-networks to monitor your online behaviour so they can display relevant ads based on your interest and online behaviour. These cookies also prevent the same ads from being displayed over and over.
